Challenges and Opportunities for Implementation of Interventions to Prevent and Control CVD in Low-Resource Settings: A Report From CESCAS in Argentina.

ADOLFO RUBINSTEIN; POGGIO ROSANA; PABLO GULAYIN

Global Heart

Elsevier

Lugar: Ginebra; Año: 2015

In Argentina, Cardiovascular diseases are estimated to cause about 100,000 deaths and more than 250,000 coronary heart disease and stroke events annually, at a cost of more than one billion international dollars. Despite progress in the implementation of several programs to combat non-communicable diseases in Argentina over the last years, most health resources are still dedicated to infectious disease and maternal and child health. The Institute for Clinical Effectiveness and Health Policy, an independent academic institution affiliated to the University of Buenos Aires medical school, runs CESCAS (South American Centre of Excellence in Cardiovascular Health), a center devoted to epidemiological, implementation and policy research. At CESCAS there are three ongoing randomized clinical trials focused on implementation science: 1) A Mobile health intervention to prevent progression of pre-hypertension in poor urban settings in Argentina, Guatemala and Peru; 2) A Comprehensive Approach for Hypertension Prevention and Control in low-resource settings in Argentina; and 3) An Educational Approach to Improve Physician Effectiveness in the Detection, Treatment and Control for patients with Hypercholesterolemia and high Cardiovascular Disease (CVD) risk in low-resource settings in Argentina. All these studies involve the design and implementation of complex interventions to change behaviors of providers and patients. The rationale of each of the three studies, the design of the interventions and the evaluation of processes and outcomes are described in this article together with the barriers and enabling factors associated with implementation research studies. There is a strong need in Argentina and the region at large to build the health research capacity and infrastructure necessary to undertake implementation studies to translate evidence from research findings into improvements in health policy and practice to address CVD and their risk factors.